title: Assessing the risk of false negative point-of-care urinary human chorionic gonadotropin device results due to beta core fragment.
authors.affiliation: Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA. Electronic address: gronowski@wustl.edu.
authors.forename: Ann M
authors.initials: AM
authors.lastname: Gronowski
authors.affiliation: Department of Pathology and Laboratory Medicine, University of Kentucky Medical Center, Lexington, KY, USA.
authors.forename: Robert D
authors.initials: RD
authors.lastname: Nerenz
mesh_terms: D018997:Chorionic Gonadotropin, beta Subunit, Human / Q000032:analysis*; D005188:False Negative Reactions; D005260:Female; D006801:Humans; D010060:Ovulation; D010446:Peptide Fragments / Q000032:analysis*; D019095:Point-of-Care Systems; D011247:Pregnancy; D011933:Reagent Kits, Diagnostic; D018570:Risk Assessment
chemical_list: D018997:Chorionic Gonadotropin, beta Subunit, Human; D010446:Peptide Fragments; D011933:Reagent Kits, Diagnostic; C063554:urinary gonadotropin fragment